The Journal of Immunology, Vol 147, Issue 5 1548-1556, Copyright © 1991 by American Association of Immunologists

ARTICLES

IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts

R Chizzonite, T Truitt, FJ Podlaski, AG Wolitzky, PM Quinn, P Nunes, AS Stern and MK Gately
Department of Molecular Genetics, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110.

IL-12, formerly known as cytotoxic lymphocyte maturation factor, is a cytokine that stimulates proliferation of PHA-activated human peripheral blood lymphoblasts and synergizes with low concentrations of IL-2 in the induction of lymphokine-activated killer cells. IL-12 is a 75-kDa heterodimer composed of disulfide-bonded 40-kDa and 35-kDa subunits. mAb prepared against a partially purified preparation of natural IL-12 have been characterized by 1) immunoprecipitation of 125I- labeled IL-12, 2) immunodepletion of IL-12 bioactivity, 3) Western blotting of IL-12, 4) inhibition of [125I]IL-12 binding to its cellular receptor, and 5) neutralization of IL-12 bioactivity. Twenty antibodies immunoprecipitate 125I-labeled IL-12 and immunodeplete IL-12 bioactivity as assessed in the T cell proliferation and lymphokine- activated killer cell induction assays. Western blot analysis demonstrated that each antibody binds to the 75-kDa heterodimer and to the 40-kDa subunit. An IL-12R-binding assay identified 12 individual antibodies that inhibited the binding of [125I]IL-12 to its cellular receptor. Two inhibitory antibodies, 4A1 and 7B2, were tested in the neutralization assay and found to block IL-12 bioactivity whereas one noninhibitory antibody, 8E3, was shown not to neutralize IL-12 bioactivity. Antibodies 4A1 and 8E3 can simultaneously bind to the 75- kDa heterodimer demonstrating that inhibitory and noninhibitory epitopes are spatially distinct on the 40-kDa protein. The ability of antibodies specific for the 40-kDa subunit of IL-12 to block receptor binding of [125I]IL-12 and to neutralize IL-12 bioactivity suggests that localized determinants on the 40-kDa subunit may be necessary for binding to the IL-12 cellular receptor.

This article has been cited by other articles:

				C.-y. Wu, X. Wang, M. Gadina, J. J. O'Shea, D. H. Presky, and J. Magram IL-12 Receptor {beta}2 (IL-12R{beta}2)-Deficient Mice Are Defective in IL-12-Mediated Signaling Despite the Presence of High Affinity IL-12 Binding Sites J. Immunol., December 1, 2000; 165(11): 6221 - 6228. [Abstract] [Full Text] [PDF]

				D. H. Presky, L. J. Minetti, S. Gillessen, V. L. Wilkinson, C.-Y. Wu, U. Gubler, R. Chizzonite, and M. K. Gately Analysis of the Multiple Interactions Between IL-12 and the High Affinity IL-12 Receptor Complex J. Immunol., March 1, 1998; 160(5): 2174 - 2179. [Abstract] [Full Text] [PDF]

				O. Devergne, M. Birkenbach, and E. Kieff Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin PNAS, October 28, 1997; 94(22): 12041 - 12046. [Abstract] [Full Text] [PDF]

				D. H. Presky, H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C.-Y. Wu, M. K. Gately, and U. Gubler A functional interleukin 12 receptor complex is composed of two beta -type cytokine receptor subunits PNAS, November 26, 1996; 93(24): 14002 - 14007. [Abstract] [Full Text] [PDF]

				S. A. Greenfeder, T. Varnell, G. Powers, K. Lombard-Gillooly, D. Shuster, K. W. McIntyre, D. E. Ryan, W. Levin, V. Madison, and G. Ju Insertion of a Structural Domain of Interleukin (IL)-1beta Confers Agonist Activity to the IL-1 Receptor Antagonist J. Biol. Chem., September 22, 1995; 270(38): 22460 - 22466. [Abstract] [Full Text] [PDF]

				S. A. Greenfeder, P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex J. Biol. Chem., June 9, 1995; 270(23): 13757 - 13765. [Abstract] [Full Text] [PDF]

				J. J. Zou, D. S. Schoenhaut, D. M. Carvajal, R. R. Warrier, D. H. Presky, M. K. Gately, and U. Gubler Structure-Function Analysis of the p35 Subunit of Mouse Interleukin 12 J. Biol. Chem., March 17, 1995; 270(11): 5864 - 5871. [Abstract] [Full Text] [PDF]

				J. E. Layton, N. E. Hall, F. Connell, J. Venhorst, and H. R. Treutlein Identification of Ligand-binding Site III on the Immunoglobulin-like Domain of the Granulocyte Colony-stimulating Factor Receptor J. Biol. Chem., September 21, 2001; 276(39): 36779 - 36787. [Abstract] [Full Text] [PDF]